AMSilk is headquartered near Munich, Germany and offers a range of high-performance biosourced polypeptides with unique functional properties in the field of cosmetics. Terms of the deal have not been disclosed and Givaudan plans to fund the transaction from existing resources. Biotech in focus Maurizio Volpi, President of Givaudan's Fragrance Division explains that the acquisition allows Givaudan to build on its offering within the biotech space for beauty. "The acquisition of the cosmetics business of AMSilk fits very well our long term strategy for Active Beauty," he explains. "It offers an expanded portfolio of natural and biosourced products supported by a strong research and development biotechnology platform to drive future development and innovation in the active cosmetic ingredients space."